In order to encourage originality and drive new drug research and development, on December 23, 2019, the Shanghai Pharmaceuticals Research Institute hosted a "Phase 9 Commendation Meeting for New Drugs Against Alzheimer's Disease", commending and rewarding the research team of Phase 9 and the project of Geng Meiyu group. More than 170 people including Academician Tang Xican, Academician Ding Jian, Director of the Institute, Research Group Leader, Research Fellow, Secretary of the Party Branch and Trade Union Representatives attended the meeting. The meeting was chaired by Tian Shenrong, deputy secretary of the party committee.
Participants first watched the episode of "The Blade of Innovation" in the CCTV documentary series "The Power of Science". This film truly and vividly shows the hardships and persistence of Researcher Geng Meiyu and his team in the research and development of the 9th phase of 22 years. Later, Director Li Jia read the congratulatory letter from the Chinese Academy of Sciences to the researcher Geng Meiyu and the Shanghai Institute of Medicine, encouraging all the people in the Institute to continuously produce original and innovative drugs, and make new and greater contributions to the construction of a healthy China and a strong country with science and technology!
Researcher Geng Meiyu gave a testimony. She told the participants the story behind the research and development of the 9th phase. She said, "If there is no drug laboratory, 971 may always be a code." She thanked the academicians, leaders, and cooperation for this effort. Research group, administrative department, R & D team, Green Valley Pharmaceutical and all superior units. She stated that she will start with the launch of the 9th phase as a new starting point, adhere to the original intention of “make medicine for patients and make conscience medicine”, live up to the patient's trust, keep in mind the mission of being a medicine person, and do a good job in the follow-up of the new phase 9 drug. Post-market real-world research, international multi-center clinical research, research on mechanism of action, and expansion of new indications.
In his speech, Academician Ding Jian cited detailed data as examples of unknown details in the Phase 9 clinical research and mechanism research. This is a R & D work in which thousands of people's congresses are teamwork and keep improving. He described Geng Meiyu, whom he knows and understands, "loves science, pursues perfection, has self-confidence, has a sense of mission, persistence, low-key, and humility." The scientific spirit and work style reflected in the first phase of the research and development period 9 are worth learning. . He encouraged the institutes to cooperate sincerely, actively respond to challenges and difficulties, tolerate loneliness, to sit on the cold bench, and to achieve more key breakthroughs in the development of new drugs.
Director Li Jia read the "Commendation Decision of Shanghai Institute of Materia Medica, Chinese Academy of Sciences on the Phase IX Research Team", and he emphasized that the successful approval of Phase IX is "the birth of Chinese scientific innovative drugs in the new era" and will lead the international The development of Alzheimer's disease drugs is a milestone in the research of new drugs in China from imitative innovation to original innovation. He called on all pharmacies to use the award-winning team as an example, to feel and learn the "power of example", "power of solidarity", and "spirit of spirit" contained in the first phase of the research and development process of the ninth phase, to promote the development of new drugs New light.
Commendation meeting site
Tian Shenrong, Deputy Secretary of the Party Committee, chaired the meeting